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Abstract—The use of a novel low power electromagnetic sensor 
for real-time detection of lactate in cerebrospinal fluid (CSF) is 
investigated. CSF holds key indicators relating to a patient’s 
future health. A multipurpose sensor platform is currently being 
developed with the capability to detect the concentration of 
materials in volumes ≤1 ml. This paper presents results from a 
microwave cavity resonator designed and created for this 
purpose, using varying concentrations of lactate in water.  The 
work demonstrates the feasibility of monitoring bodily fluids in 
real-time.  Such advancements are essential for improved and 
cost-effective delivery of healthcare services to patients.  
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I. INTRODUCTION 
Cerebrospinal fluid (CSF) is a clear, colourless 
bodily fluid produced in the brain which occupies 
the subarachnoid space and the ventricular system 
around and inside the brain and spinal cord. CSF is 
produced at a rate of 0.2-0.7 ml/min, or 
approximately 600-700 ml/day, and provides 
buoyancy for the brain, protecting it from injury in 
the event of jolting. In addition it plays an important 
role in the homeostasis and metabolism of the 
central nervous system (CNS) since it rinses 
metabolic waste through the blood brain barrier and 
back into the bloodstream. 
Patients who are undergoing surgical or 
endovascular aneurysm repair (EVAR) of acute and 
chronic thoraco-abdominal aortic disease [1, 2] 
have an inherent risk of paraplegia. This is caused 
by restriction of the spinal cord blood flow and lack 
of oxygen during the procedures, typically referred 
to as spinal cord ischemia [3]. Despite the use of 
various strategies for the prevention of spinal cord 
ischemia, paraplegia and paraparesis continue to 
occur after thoracoabdominal aortic aneurysm 
repair. CSF drainage is often used as an adjunct for 
spinal cord protection [4]. This procedure reduces 
the pressure upon the spinal cord and thus the risk 
of paraplegia is decreased. At the moment any CSF 
collected would normally be discarded as biological 
waste.  
CSF analysis currently comprises a group of 
laboratory tests that measure antibodies and DNA 
of common viruses, bacteria, cell count, chloride, 
cryptococcal antigen, glucose, glutamine, lactate 
dehydrogenase, oligoclonal banding to look for 
specific proteins, total protein and whether there are 
cancerous cells present [5]. Analysis of CSF 
biomarkers is an integral part of neurology and the 
aforementioned techniques have been used to 
diagnose inflammatory and infectious CNS 
disorders in adults and children for decades. During 
recent years, however, numerous biomarkers for 
neuronal and astroglial injury, as well as disease-
specific protein inclusions, have been developed for 
neurodegenerative disorders in adults [6]. 
With the development of CSF biomarkers that 
reflect pathological events within CNS, important 
clinical diagnostic tools are becoming available [7]. 
Biomarkers for specific pathogenetic processes 
would also be valuable tools both to study disease 
pathogenesis directly in patients and to identify and 
monitor the effect of novel treatment strategies. 
Advancing from the current laboratory based 
analysis techniques to online methods could provide 
the basis for improved patients’ treatment regimes, 
better quality of care, and enhanced resource 
efficiency within hospitals. 
Therefore, researchers at Liverpool Heart and 
Chest Hospital (LHCH) and Liverpool John Moores 
 University (LJMU) in the UK believe that real-time 
CSF analysis could harbour important information 
which may indicate sub-clinical cord ischemia and 
compromise.  This is supported by work conducted 
by Drenger et al [8], who observed that lactate 
concentration in CSF increased with the onset of 
patient paraplegia. Three cerebral biochemical 
markers, adenylate kinase (AK), neuron-specific 
enolase (NSE) and protein S-100 can be determined 
in the CSF after coronary artery bypass grafting [1]. 
Moreover, protein S-100B, neuron-specific enolase, 
myelin basic protein and glial fibrillary acidic 
protein in CSF and blood of patients with an acute 
or chronic progressive neurological disorder with 
brain damage are important indicators for medical 
practitioners. Particularly in disorders with acute 
brain damage, determination of the aforementioned 
proteins in CSF and blood can be helpful to 
establish structural and/or functional brain damage 
to determine severity and prognosis of the disease 
process and to monitor treatment effects [9]. 
The normal physiological level of lactate in blood 
or CSF is approximately 1 mmol; in pathology it 
may rise to around 10-15 mmol, or in exercise even 
higher [10]. CSF analysis would be most practical 
immediately after it has been drained from a patient, 
allowing a surgeon to take immediate actions.  In 
many cases this could remove the need for 
subsequent surgical procedures, thus improving the 
efficiency of hospital resources and arguably 
improving patient care. 
Notably, biomarkers of α-synuclein pathology 
and other pathologies associated with Parkinson's 
disease (PD), dementia with Lewy bodies (DLB) 
and frontotemporal dementia (FTD) are currently 
under intense investigation [7]. 
Moreover, transmeningeal pharmacotherapy for 
cerebral cortical disorders requires drug delivery 
through the subdural/subarachnoid space, ideally 
with a feedback controlled mechanism. A device 
suitable for this function has been recently 
developed [11], which is equipped with fluid-
exchange ports for both drug delivery and local CSF 
removal.  
Through the use of electromagnetic sensing, in 
particular microwave techniques, it is proposed that 
the key requirement of CSF analysis, namely 
timeliness and precision, could be met. Microwave 
sensors provide a rapid non-invasive method of 
material analysis, which is robust and has huge 
potential for a wide range of biomedical 
applications. In addition, microwave analysis 
promises the potential for inexpensive equipment, 
therefore increasing the attractiveness of any device 
placed into operating theatres, particularly 
considering the strained nature of many hospital 
budgets. Microwave spectroscopy has seen use for a 
variety of purposes, including monitoring of water 
quality [12], filter monitoring [13] and also for use 
monitoring oil, gas and water concentrations [14]. It 
is thought that the use of microwave spectroscopy, 
as in the previously mentioned applications, will 
provide affordable and rapid diagnostics for the 
healthcare scenario described in this work.  Notably, 
the technique is also non-ionising, utilising (at most) 
one-tenth the power required for transmission by a 
typical modern day mobile phone; it is therefore 
thought safe for use during surgical procedures. 
Medical professionals would find the prospect of 
online detection of such analytes exciting, as current 
practice is time consuming and leads to multiple 
invasive procedures. 
This work is being carried out as part of a 
collaborative venture between LJMU and LHCH.  
As a precursor to testing on human samples this 
work considers the microwave response of a 
bespoke sensor system when varying the level of 
lactate in water. 
II. THEORY OF OPERATION 
A.  Electromagnetic Waves 
Electromagnetic (EM) waves are waves of energy 
that travel through a vacuum at the speed of light, 
approximately c=3×108 m/s. EM waves consist of 
two primary components: an electric (E) field and a 
magnetic (H) field [15]. The electric field and 
magnetic field oscillate in phase perpendicular to 
each other and perpendicular to the direction of 
energy propagation. EM waves can be visualised as 
a sinusoidal wave.  
EM waves can be used to analyse lactate due to 
their material specific interaction properties. This 
technique has a number of advantages, making it 
suitable for biomedical applications. Analysis using 
microwaves is non-ionising with a low power 
output of approximately 1mW (0 dBm). They have 
 a good penetration depth and associated equipment 
can be portable for use at the bedside. The multi-
parameter nature of wide band microwave analysis 
can provide unique signal spectrum signatures.  
Typically these would be in the form of a reflected 
signal S11 or/and a transmitted signal |S21|, which 
are influenced by parameters such as conductivity 
and permittivity [16]. Conductivity is a measure of 
a material’s ability to conduct an electric current.  
Permittivity relates to a material’s ability to transmit 
an electric field and is a complex value which varies 
with frequency, and accounts for the energy stored 
by a material (ε') as well as any losses of energy (ε'') 
which might occur. 
B.  Microwave Cavity 
Microwave cavities are widely used for 
characterising the properties of materials [17-19] 
including characterisation of stimulation-mediated 
cell signaling responses [20]. A cavity is usually 
made by shorting the two ends of a waveguide 
segment. The electrical power is transported through 
the waveguide by means of electromagnetic waves, 
which can take several different forms (modes), 
depending on the frequency, the dimensions and the 
material properties inside.  
The different configurations of electric and 
magnetic field which can exist in a waveguide are 
known as transverse electromagnetic (TEM) modes. 
The transverse electric (TE) and transverse magnetic 
(TM) are the two types of modes which usually exist 
in the waveguide. 
A cavity will resonate when it is excited at an 
appropriate frequency.  In the case of this work, the 
cavity is excited by a circular patch antenna placed 
inside it. The resonant modes occur when the 
electric and magnetic fields form standing waves, 
which depend on the internal dimensions of the 
cavity and the dielectric properties of the lactate in 
water used for this work. Therefore, its relative 
permittivity (εr) will change. The resonant 
frequency for TEnml and TMnml modes [21] in a 
circular waveguide can be calculated using (1): 
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where: c is the speed of light 
r is of the relative permeability 
r is the relative permittivity 
pnm is the value of the Bessel function for the 
TE or TM modes of a circular waveguide 
a is the radius of the cavity 
d is the height of the cavity. 
Therefore, all TE and TM modes are dependent 
on √εr, so when the waveguide is excited by a range 
of frequencies, the magnitude signal spectrum is 
captured and resonant peaks corresponding to these 
particular modes will shift to lower frequencies as 
the permittivity is increased. 
C.  High Frequency Structure Simulator (HFSS) 
Ansys High Frequency Structure Simulator 
(HFSS) is a 3D full wave EM field simulation 
package which can be used to design microwave 
structures [22]. HFSS allows complex geometries to 
be created, which is particularly useful in these sorts 
of applications.  The outputs of HFSS include S-
parameters, Full-Wave SPICE extraction and 3D 
electromagnetic field simulation [23]. 
The TE and TM modes for the circular cavity 
used for this work have been simulated using HFSS. 
Fig. 1 shows some of the configurations for the TM 
modes in a cylindrical waveguide, with the red 
colour representing the maximum field intensity and 
the blue colour representing the minimum.  
 
  
Fig. 1  Modes in a cylindrical cavity: (a) TM010, (b) TM210, (c) TM310, (d) TM220. 
III. RESEARCH METHOD 
A. Preparation of Lactic Acid 
Serial dilutions of L(+)-lactic acid were prepared 
to cover a range from low, physiological to 
supraphysiological levels (0-64 mmol/l) in distilled 
water. Sample concentrations were as follows: 
0 mmol (water), 0.5 mmol, 2 mmol, 4 mmol, 
8 mmol, 16 mmol, 32 mmol and 64 mmol. All of the 
samples were stored in a refrigerated unit at 
temperatures in the region of 5 °C. Samples were 
removed only to be exposed to the cavity for a short 
period of time, after which they were returned to the 
refrigerator.   
The evaluation of the proposed novel microwave 
technology for real-time bodily fluid analysis was 
performed on a lactate, since it is a marker of 
ischemia in CSF. There are two reasons for this: (1) 
lactate is relatively inexpensive and (2) CSF 
provides a relatively simple background which can 
be synthesised in-vitro.  A small sample volume of 
0.5 ml, which is enough to saturate the internal 
cavity volume, is placed in a glass tube (0.5 mm 
diameter and 180 mm in length). 
B. Acquisition Measurement 
Measurement was performed using a ZVL-6 
Rohde and Schwarz Vector Network Analyser 
(VNA). The instrument can generate frequencies up 
to 6 GHz. Measurement was made via the cavity 
discussed in Section II. Fig. 2 shows the patch 
antenna placed in the bottom of the cavity. The 
bottom port, which was soldered inside the cavity to 
the patch antenna, was attached to the VNA output 
port. This means that it was only possible to measure 
the S11 parameter.  Temperature variations were 
minimised through the use of an environmental 
chamber.  The results have been found to be 
repeatable through numerous spectra acquisitions for 
each sample over the course of a week. 
  
 
Fig. 2  Experimental setup for lactate measurement, with cavity shown (left) dismantled and (right) in use for analysis. 
 
 
Fig. 3  Experimental spectra from 800-2000 MHz, shown as a normalised reflected power (µW). The direction of the arrow indicates the increasing peak 
amplitudes with the increasing lactate acid concentration. 
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 To perform the analysis, samples were removed 
from the refrigerator, then placed into the cavity and 
the spectrum S11 was captured directly. As it takes 
less than 2 seconds for the full spectra capture, 
depending on the desired number of points, the 
analysis is truly real-time, which is vital for both 
patients and medical practitioners. The cavity was 
designed to accept sample containers within 0.5 mm 
diameter glass tubes, which must contain identical 
fluid volumes above the internal height of cavity. 
This system facilitates empirical analysis of small 
volume of materials presented to the cavity and is 
useful for determining specific areas of interest in 
the microwave spectrum.  
 
Fig. 4  Linear representation of peak amplitudes from the resonant cavity in 
the range of 800-2000 MHz. 
IV. RESULTS 
The spectrum for each lactate sample has been 
normalised against a 0 mmol (water) sample for 
ease of viewing and analysis. The results shown in 
Fig. 3 have been converted from the logarithm 
(dBm) scale to a linear (µW) scale. There are three 
peaks of interest at approximately (1) 1040 MHz, (2) 
1532 MHz, and (3) 1888 MHz.  The main interest 
at these peaks is the shift in signal amplitude. 
It is clear to the eye that the sensor response is 
reasonably linear, particularly at higher lactate 
concentrations.  For lower concentrations, Fig. 4 has 
been produced to confirm linearity for these peaks, 
in addition to the third peak shown in Fig. 3.  This 
later peak however suffers from a loss of precision 
at lower concentrations.  
Assuming the near linear relationship discovered 
between peak amplitude and concentration, the 
results in Fig. 4 suggest that at 1040 MHz, the 
sensor response is 2.5 µW/mmol/l, while at 
1532 MHz it is reduced to 2.1 µW/mmol/l.  At 
1888 MHz, the relationship can be said to be 
0.86 µW/mmol/l provided the concentration of 
lactate is > 10 mmol/l. The results are repeatable and 
reproducible. 
Thus, online monitoring of bodily fluids is shown 
to be possible, which could lead to significant 
clinical improvements realised via real-time 
information provided during surgical procedures. 
Such information gives the opportunity for rapid 
analysis of material in order to determine a, 
potentially immediate, course of remedial action for 
a patient. 
Future elements of the work will consider the 
ability to rapidly scan biological fluids and tissues 
ex-vivo at the bedside.  In addition, rapid detection 
of cancer cells or tumour architecture, which can 
also be applied to samples of sputum, lung nodules, 
and biopsies of oesopageal, lung and lymph tissue 
is possible and is being considered by the authors 
[24]. Ultimately however, the ability to gain useful 
information from microwave scans of tissues in-
vivo could serve to avoid a range of invasive 
diagnostic procedures. 
V. CONCLUSIONS 
A novel resonant cavity sensor reported in this 
paper has shown promising results for lactate in 
water, with a linear response being apparent at 
1040 MHz (2.5 µW/mmol/l) and at 1532 MHz 
(2.1 µW/mmol/l). Importantly, it was proven that 
differing concentrations of lactate can be determined 
based on the changing dielectric properties of the 
resulting material, which leads us to believe that this 
technique could also be applied to human CSF.   
Further work is ongoing in order to determine the 
effect of other more complex background media, as 
one might find in the human body.  Provided the 
method can operate within the context of more 
complex media, this work shows significant promise 
toward developing a rapid testing mechanism for 
use during surgery.  This will inevitably lead to 
fewer subsequent surgical procedures which will be 
beneficial to patients and healthcare organisations 
alike. 
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